THERANEXUS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.135 EUR | +1.34% |
|
+8.10% | +1.34% |
| 04-19 | Theranexus: share price rises following promising trial results | CF |
| 03-11 | Theranexus: CEO takes over as Chairman of the Board | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| THERANEXUS | Bio Therapeutic Drugs | +1.34% | +8.10% | +1.34% | -17.03% | -81.93% | 9.4M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALTHX Stock
- Charts Theranexus
- Comparison Chart
